Phosphate ion
- Generic Name
- Phosphate ion
- Drug Type
- Small Molecule
- Chemical Formula
- O4P
- CAS Number
- 14265-44-2
- Unique Ingredient Identifier
- NK08V8K8HR
Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Target Recruit Count
- 12
- Registration Number
- NCT00876655
- Locations
- 🇺🇸
Covance Clinical Research Unit, Austin, Texas, United States
A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
- First Posted Date
- 2008-08-15
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Healios K.K.
- Registration Number
- NCT00735683
Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy
- Conditions
- Colonoscopy
- Interventions
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT00558376
- Locations
- 🇮🇱
Sheba_Medical_Center, Tel-Hashomer, Israel
Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
- Conditions
- Hereditary Angioedema (HAE)
- Interventions
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Shire
- Target Recruit Count
- 96
- Registration Number
- NCT00457015
- Locations
- 🇺🇸
Kansas City Allergy & Asthma, Overland Park, Kansas, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸University Consultants in Allergy and Immunology, Chicago, Illinois, United States
A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy
- Conditions
- Colonoscopy
- Interventions
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2015-09-22
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 315
- Registration Number
- NCT00410215
- Locations
- 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada
Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery
- Conditions
- Ocular Inflammation
- First Posted Date
- 2006-07-19
- Last Posted Date
- 2006-07-28
- Lead Sponsor
- Evolutec Group
- Registration Number
- NCT00353964
- Locations
- 🇺🇸
ORA Study Sites, North Andover, Massachusetts, United States
Dialysis Clinical Outcomes Revisited (DCOR) Trial
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Genzyme, a Sanofi Company
- Target Recruit Count
- 2000
- Registration Number
- NCT00324571
- Locations
- 🇺🇸
nTouch Research, Raleigh, North Carolina, United States
🇺🇸Gambro Healthcare-Hartford, Hartford, Connecticut, United States
🇺🇸Nephrology Associates, P.C., Columbus, Mississippi, United States
MOVIPREP® Versus NaP Pivotal Phase III Study
- Conditions
- Colonoscopy
- Interventions
- First Posted Date
- 2006-05-04
- Last Posted Date
- 2008-04-16
- Lead Sponsor
- Norgine
- Target Recruit Count
- 340
- Registration Number
- NCT00322062
- Locations
- 🇫🇷
Hôpital De L'Archet, Nice cedex 3, France
🇫🇷Hôpital Trousseau CHRU, Tours, France
🇫🇷Hôpital Dupuytren, Limoges, France
Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
- Conditions
- Hereditary Angioedema (HAE)
- Interventions
- First Posted Date
- 2005-12-06
- Last Posted Date
- 2021-06-11
- Lead Sponsor
- Shire
- Target Recruit Count
- 91
- Registration Number
- NCT00262080
- Locations
- 🇺🇸
Institute for Asthma and Allergy, Wheaton, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.